Erratum:Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy  

作　　者：Tina Boortalary Ernest Rosato Christopher Roth Xiangdong David Ren Selena YLin Hie-Won Hann 

机构地区：[1]Department of Medicine,Thomas Jefferson University Hospital,Philadelphia,PA 19107,USA [2]Department of Surgery,Thomas Jefferson University Hospital,Philadelphia,PA 19107,USA [3]Department of Radiology,Thomas Jefferson University Hospital,Philadelphia,PA 19107,USA [4]Reniguard Life Sciences Inc.,Malvern,PA 19355,USA [5]JBS Science,Inc.,Doylestown,PA 18902,USA [6]Division of Liver Disease Prevention Center,Division of Gastroenterology and Hepatology,Thomas Jefferson University Hospital,Philadelphia,PA 19107,USA

出　　处：《Hepatoma Research》2022年第1期380-380,共1页肝癌研究（英文版）

摘　　要：This is an Erratum of the publsihed paper:Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy.The ethical approval and consent to participation information were missing in the DECLARATIONS section due to the production issue.The original article has been updated.

关 键 词：SURGERY HEPATOCELLULAR HEPATITIS 

分 类 号：R73[医药卫生—肿瘤]